Same-day preeclampsia test rolled out in UK


A same-day blood test that can rule out preeclampsia in pregnant women is being rolled out across the National Health Service (NHS) in England.

The NHS is a publicly funded health care system and 1 of 4 in the United Kingdom.

Preeclampsia is dangerous for both mother and baby and can often lead to preterm birth and even increase the risk of stroke later in life in women with a history of preeclampsia.

The test—placental growth factor (PLGF) testing—is the first of its kind to exclude the life-threatening condition and is being used in 75% of the maternity wards in England. According to an article from Independent, 65,000 expectant mothers are admitted to the hospital for up to 3 days to be monitored each year. The blood test can be used, according to research, to indicate who needs admission and intensive monitoring, and who can be discharged.

Normal test results mean that preeclampsia is not developing over the next 1-2 weeks, and the mother can safely resume her routine antenatal surveillance.

This test, and further research on its effectiveness, may shed light on ways U.S. health care systems can better aid women with high blood pressure and/or preeclampsia.

Related Videos
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit:
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:
The impact of smoking cessation on pregnancy outcomes | Image Credit:
Maximizing maternal health: The impact of exercise during pregnancy | Image Credit:
The importance of nipocalimab’s FTD against FNAIT | Image Credit:
Fertility treatment challenges for Muslim women during fasting holidays | Image Credit:
CDC estimates of maternal mortality found overestimated | Image Credit:
Study unveils maternal mortality tracking trends | Image Credit:
How Harmonia Healthcare is revolutionizing hyperemesis gravidarum care | Image Credit:
Related Content
© 2024 MJH Life Sciences

All rights reserved.